Back to the main directory
Company Analysis / Equity
- Morningstar | IQVIA's Life Sciences Cloud Business Continues to Soar; Raising FVE to $131 Following Investor Day. See Updated Analyst Note from 19 Jun 2019 by Morningstar
- Hannover Re Reports Full-Year 2018; Life and Health Back on Track, but Shares Still Overvalued by Morningstar
- Morningstar | Raising Haitian’s FVE to CNY 56 on Higher Profit Growth Forecast, but Shares Overvalued. See Updated Analyst Note from 27 Mar 2019 by Morningstar
- Morningstar | China Vanke's 1Q Earnings Slightly Below Expectations due to Large Minority Interest by Morningstar
- Morningstar | Netwealth’s Still Looks Expensive Despite Further Strong FUMA Growth by Morningstar
- Morningstar | Turkey Turnaround for Allianz and Traditional Life Investment Margin Headwinds Persist by Morningstar
- Prime One-Day Shipping Offers Defensive and Offensive Benefits to Amazon's Long-Term Cash Flow Story by Morningstar
- Morningstar | Aptar's Performance Will Strengthen Under a Renewed Focus on Cost Restructuring by Morningstar
- Morningstar | Fed Maintains Policy Rate, No Real Surprises During the May Meeting by Morningstar
- Morningstar | Fed Maintains Policy Rate, No Real Surprises During the May Meeting by Morningstar
- Chevron Turns to the Permian for the Next Phase of Its Growth by Morningstar
- Morningstar | Fed Maintains Policy Rate, No Real Surprises During the May Meeting by Morningstar
- Morningstar | Fed Maintains Policy Rate, No Real Surprises During the May Meeting by Morningstar
- Offshore Drillers Face Long-Term Outlook of Meager Utilization by Morningstar
- Morningstar | Fed Maintains Policy Rate, No Real Surprises During the May Meeting by Morningstar
- Morningstar | HollyFrontier is Well Positioned to Capture Ongoing Crude Discounts by Morningstar
- Morningstar | Fed Maintains Policy Rate, No Real Surprises During the May Meeting by Morningstar
- Morningstar | Ingersoll Rand's Focus on Sustainability Should Support Long-Term Growth by Morningstar
- Morningstar | Fed Maintains Policy Rate, No Real Surprises During the May Meeting by Morningstar
- Morningstar | Placing L3 Technologies Under Review. See Updated Analyst Note from 23 Apr 2019 by Morningstar
- Morningstar | Littelfuse an Attractive Power Play; Initiating With $190 Fair Value Estimate, Narrow Moat. See Updated Analyst Note from 14 Jun 2019 by Morningstar
- We Assign Lockheed Martin a $328 Fair Value Estimate by Morningstar
- Rate Cuts Present Surmountable Headwinds For M&T by Morningstar
- Teva and Mylan Are Adapting to the Challenging Generic Industry Dynamics by Morningstar
- Ormat's Lack of Margin Improvement Leads Us to Lower Our Fair Value Estiamte by Morningstar